Nano-X Imaging (NNOX) earnings call transcripts

Management framed the quarter as an execution reset, with commercialization improving but still dependent on deployment workflows and partner-led scale.

Management reframed the year around operational milestones after withdrawing revenue guidance, emphasizing channel-led commercialization while acknowledging slower-than-expected deployment and financing needs.

Management framed 2026 as a deployment-led inflection, while acknowledging that activation timing and partner execution make the revenue target back-half weighted.

Management framed 2026 growth around ARC deployments, AI expansion and partnerships, while acknowledging regulatory and installation dependencies.